-Advertisement-
-Advertisement-

Exclusives

Dextenza Implant Effective as Standard Topical Steroid Regimen

Dextenza implant is effective as a standard topical steroid regimen for the prevention of post-op pain and inflammation in cataract and cataract/MIGS surgical patients In 2019,  Ocular Therapeutix, Inc received FDA approval of a supplemental new drug application (sNDA) for Dextenza to include the treatment of ocular inflammation following ophthalmic...

Read More
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-